Annual General Meeting

of Chemomab Therapeutics Ltd.

Date:	June 10, 2024
	See Voting Instruction On Reverse Side.

Please make your marks like this: ☒ Use dark black pencil or pen only

		For	Against	Abstain
1.	To re-elect each of Dr. Adi Mor and Dr. Alan Moses as Class III directors, to hold office until the close of the Company’s annual general meeting of shareholders in 2027, and until their respective successors are duly elected and qualified, or until their respective offices are vacated in accordance with our Articles of Association (the “Articles”) or the Israeli Companies Law 5759-1999;

	1a. Dr. Adi Mor	☐	☐	☐

	1b. Dr. Alan Moses	☐	☐	☐

2.	To approve an increase of the Company’s authorized share capital and to amend the Company’s Articles accordingly.	☐	☐	☐

3.	To approve the re-appointment of Somekh Chaikin, a member firm of KPMG International, as the Company’s independent registered public accounting firm for the year ending December 31, 2024, and to authorize the Company’s board of directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors.	☐	☐	☐

Authorized Signatures - This section must be

completed for your instructions to be executed.

__________________________________	__________________________________
Please Sign Here	Please Date Above

__________________________________	__________________________________
Please Sign Here	Please Date Above

↑ Please separate carefully at the perforation and return just this portion in the envelope provided. ↑

Annual General Meeting of Chemomab Therapeutics Ltd.

to be held on June 10, 2024

For Holders as of April 25, 2024

MAIL

	•	Mark, sign and date your Voting Instruction Form.
	•	Detach your Voting Instruction Form.
	•	Return your Voting Instruction Form in the postage-paid envelope provided.

All votes must be received by 12:00 p.m. EST on June 3, 2024.

	PROXY TABULATOR FOR
	CHEMOMAB THERAPEUTICS LTD.
	P.O. BOX 8016
	CARY, NC 27512-9903

EVENT #

CLIENT #

Chemomab Therapeutics Ltd.

Instructions to The Bank of New York Mellon, as Depositary

Must be received prior to 12:00 p.m. EST on June 3, 2024

The undersigned registered owner of American Depositary Shares hereby requests and instructs The Bank of New York Mellon, as Depositary, to endeavor, insofar as practicable, to vote or cause to be voted the amount of Ordinary Shares or other Deposited Securities represented by such American Depositary Shares of Chemomab Therapeutics Ltd. registered in the name of the undersigned on the books of the Depositary as of the close of business on April 25, 2024 at the Annual General Meeting of the Shareholders of Chemomab Therapeutics Ltd. to be held on June 10, 2024 or any postponement or adjournment thereof in respect of the resolutions specified on the reverse.

NOTES:

1.	Please direct the Depositary how it is to vote by placing an “X” in the appropriate box opposite each agenda item.

PROXY TABULATOR FOR

CHEMOMAB THERAPEUTICS LTD.

P.O. BOX 8016

CARY, NC 27512-9903